Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1979 Jun 16;1(6178):1591–1594. doi: 10.1136/bmj.1.6178.1591

Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy.

E D Gallery, D M Saunders, S N Hunyor, A Z Györy
PMCID: PMC1599149  PMID: 466138

Abstract

Fifty-three pregnant women with moderately severe hypertension were randomly allocated to treatment with methyldopa or oxprenolol. There were no significant differences between the groups in age, height, weight, parity, or stage of gestation at the start of treatment. The outcome of pregnancy was better in the group treated with oxprenolol, with greater maternal plasma volume expansion and placental and fetal growth. No intrauterine deaths occurred in either group, and antepartum fetal distress, detected by oxytocin challenge testing, was evident in only one patient, who received methyldopa. This infant, and one other in the methyldopa group, died in the neonatal period. No neonatal deaths occurred in the oxprenolol-treated group. Even in this small number of patients these results were considerably better than those in untreated women with hypertension of similar severity. Apgar scores in both groups were equivalent at birth, while blood sugar concentrations were higher in the oxprenolol group. Oxprenolol appears to be safe and effective in controlling hypertension during pregnancy. There was no evidence of harmful effects on the fetus, and oxprenolol may offer a selective advantage over methyldopa for fetal growth and wellbeing in utero.

Full text

PDF
1591

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amy J. J., Karim S. M. Intrauterine administration of L-noradrenaline and propanolol during the second trimester of pregnancy. J Obstet Gynaecol Br Commonw. 1974 Jan;81(1):75–83. doi: 10.1111/j.1471-0528.1974.tb00368.x. [DOI] [PubMed] [Google Scholar]
  2. Arias F. Expansion of intravascular volume and fetal outcome in patients with chronic hypertension and pregnancy. Am J Obstet Gynecol. 1975 Nov 15;123(6):610–616. doi: 10.1016/0002-9378(75)90883-2. [DOI] [PubMed] [Google Scholar]
  3. Barden T. P., Stander R. W. Effects of adrenergic blocking agents and catecholamines in human pregnancy. Am J Obstet Gynecol. 1968 Sep 15;102(2):226–235. doi: 10.1016/0002-9378(68)90323-2. [DOI] [PubMed] [Google Scholar]
  4. Barden T. P., Stander R. W. Myometrial and cardiovascular effects of an adrenergic blocking drug in human pregnancy. Am J Obstet Gynecol. 1968 May 1;101(1):91–99. doi: 10.1016/0002-9378(68)90491-2. [DOI] [PubMed] [Google Scholar]
  5. Fiddler G. I. Letter: Propranolol and pregnancy. Lancet. 1974 Sep 21;2(7882):722–723. doi: 10.1016/s0140-6736(74)93301-7. [DOI] [PubMed] [Google Scholar]
  6. Gallery E. D., Hunyor S. N., Ross M., Györy A. Z. Predicting the development of pregnancy-associated hypertension. The place of standardised blood-pressure measurement. Lancet. 1977 Jun 18;1(8025):1273–1275. doi: 10.1016/s0140-6736(77)91316-2. [DOI] [PubMed] [Google Scholar]
  7. Gibson H. M. Plasma volume and glomerular filtration rate in pregnancy and their relation to differences in fetal growth. J Obstet Gynaecol Br Commonw. 1973 Dec;80(12):1067–1074. doi: 10.1111/j.1471-0528.1973.tb02981.x. [DOI] [PubMed] [Google Scholar]
  8. Gladstone G. R., Hordof A., Gersony W. M. Propranolol administration during pregnancy: effects on the fetus. J Pediatr. 1975 Jun;86(6):962–964. doi: 10.1016/s0022-3476(75)80236-8. [DOI] [PubMed] [Google Scholar]
  9. Habib A., McCarthy J. S. Effects on the neonate of propranolol administered during pregnancy. J Pediatr. 1977 Nov;91(5):808–811. doi: 10.1016/s0022-3476(77)81048-2. [DOI] [PubMed] [Google Scholar]
  10. Kincaid-Smith P., Bullen M., Mills J. Prolonged use of methyldopa in severe hypertension in pregnancy. Br Med J. 1966 Jan 29;1(5482):274–276. doi: 10.1136/bmj.1.5482.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Leather H. M., Humphreys D. M., Baker P., Chadd M. A. A controlled trial of hypotensive agents in hypertension in pregnancy. Lancet. 1968 Aug 31;2(7566):488–490. doi: 10.1016/s0140-6736(68)90650-8. [DOI] [PubMed] [Google Scholar]
  12. Ledwich J. R., Fay J. E. Idiopathic recurrent ventricular fibrillation. Am J Cardiol. 1969 Aug;24(2):255–258. doi: 10.1016/0002-9149(69)90412-3. [DOI] [PubMed] [Google Scholar]
  13. Lieberman B. A., Stirrat G. M., Cohen S. L., Beard R. W., Pinker G. D., Belsey E. The possible adverse effect of propranolol on the fetus in pregnancies complicated by severe hypertension. Br J Obstet Gynaecol. 1978 Sep;85(9):678–683. doi: 10.1111/j.1471-0528.1978.tb14946.x. [DOI] [PubMed] [Google Scholar]
  14. Neutra R. Fetal death in eclampsia: I. Its relation to low gestational age, retarded fetal growth and low birthweight. Br J Obstet Gynaecol. 1975 May;82(5):382–389. doi: 10.1111/j.1471-0528.1975.tb00653.x. [DOI] [PubMed] [Google Scholar]
  15. Redman C. W. Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet. 1976 Oct 9;2(7989):753–756. doi: 10.1016/s0140-6736(76)90597-3. [DOI] [PubMed] [Google Scholar]
  16. Reed R. L., Cheney C. B., Fearon R. E., Hook R., Hehre F. W. Propranolol therapy throughout pregnancy: a case report. Anesth Analg. 1974 Mar-Apr;53(2):214–214. [PubMed] [Google Scholar]
  17. Tarazi R. C., Dustan H. P., Frohlich E. D., Gifford R. W., Jr, Hoffman G. C. Plasma volume and chronic hypertension. Relationship to arterial pressure levels in different hypertensive diseases. Arch Intern Med. 1970 May;125(5):835–842. doi: 10.1001/archinte.125.5.835. [DOI] [PubMed] [Google Scholar]
  18. Thomson A. M., Billewicz W. Z., Hytten F. E. The weight of the placenta in relation to birthweight. J Obstet Gynaecol Br Commonw. 1969 Oct;76(10):865–872. doi: 10.1111/j.1471-0528.1969.tb15722.x. [DOI] [PubMed] [Google Scholar]
  19. Truelove J. F., van Petten G. R., Willes R. F. Action of several -adrenoceptor blocking drugs in the pregnant sheep and foetus. Br J Pharmacol. 1973 Jan;47(1):161–171. doi: 10.1111/j.1476-5381.1973.tb08170.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Van Petten G. R., Willes R. F. Beta-adrenoceptive responses in the unanaesthetized ovine foetus. Br J Pharmacol. 1970 May;38(3):572–582. doi: 10.1111/j.1476-5381.1970.tb10598.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wansbrough H., Nakanishi H., Wood C. The effect of adrenergic receptor blocking drugs on the human uterus. J Obstet Gynaecol Br Commonw. 1968 Feb;75(2):189–198. doi: 10.1111/j.1471-0528.1968.tb02031.x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES